About BAVENCIO® (avelumab)

You are about to leave this site and are being redirected to another site. Would you like to leave this site?

Image-1

Image-1

BAVENCIO® (avelumab) is an immunotherapy—a medicine that may help your immune system fight metastatic MCC

BAVENCIO treats metastatic MCC

  • BAVENCIO is used after MCC has spread to other parts of your body, or metastasized
  • BAVENCIO is a man-made antibody. Your body naturally produces antibodies to help your immune system work
  • BAVENCIO is the only medicine that the Food and Drug Administraion (FDA) has approved to treat metastatic MCC
  • BAVENCIO is delivered by an intravenous (IV) infusion directly into your bloodstream

BAVENCIO may engage both your adaptive and innate immune systems

  • The immune system is a part of your body that fights diseases to keep you healthy

  • One job of your immune system is to remove cells that are becoming cancerous

  • Over time, cancer cells may be able to stop your immune system from attacking them

Your adaptive immune system learns to identify and adapt to threats over time, and delivers a response to defend you against specific threats

Your innate immune system is your first line of defense against general threats